<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/10321" />
  <subtitle />
  <id>http://localhost:8080/xmlui/handle/123456789/10321</id>
  <updated>2026-04-09T00:14:21Z</updated>
  <dc:date>2026-04-09T00:14:21Z</dc:date>
  <entry>
    <title>Carbetosine, a Long-acting Oxytocin Agonist, as a Uterotonic in the Prevention of the Occurrence of Postpartum Bleeding</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/10390" />
    <author>
      <name>Izaak, Revynca Petronella</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/10390</id>
    <updated>2025-06-05T04:43:21Z</updated>
    <published>2024-01-01T00:00:00Z</published>
    <summary type="text">Title: Carbetosine, a Long-acting Oxytocin Agonist, as a Uterotonic in the Prevention of the Occurrence of Postpartum Bleeding
Authors: Izaak, Revynca Petronella
Abstract: Objective: To evaluate the comparative effect of carbetocin versus other uterotonic agents (misoprostol and oxytocin) in&#xD;
preventing postpartum bleeding.&#xD;
Methods: Medical search engines such as Pubmed, Google Scholar, and Cochrane were used for literature searches. The&#xD;
literature covered the period from 2013 to 2023. Keywords used were “Carbetocin” or “long-acting oxytocin” and “uterotonic”,&#xD;
“post-partum hemorrhage” or “post-partum bleeding.” Data analysis was conducted using the RevMan 5.4 application.&#xD;
Results: This study involved 12 clinical trials involving a total sample of 32,312 people. Based on forest plot analysis, it was&#xD;
found that patients receiving carbetocin therapy had a 0.42 times lower risk of developing postpartum compared to those&#xD;
receiving other uterotonic agents (misoprostol and oxytocin) (OR: 0.42; 95% CI: 0.26-0.68; p&lt;0.0004; with heterogeneity&#xD;
p&lt;0.00001, I2 85%)&#xD;
Conclusion: Carbetocin, with its effectiveness and efficacy, can be considered as one modality for preventing postpartum&#xD;
hemorrhage in comparison to other uterotonic agents, such as misoprostol and oxytocin. In addition to that, it can benefit&#xD;
women at risk of having a major obstetric hemorrhage</summary>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Unusual Location: Omental Ectopic Pregnancy Interesting Case Report</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/10389" />
    <author>
      <name>Tamara, Yosi</name>
    </author>
    <author>
      <name>Singgih, Rendy</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/10389</id>
    <updated>2025-06-05T03:50:02Z</updated>
    <published>2024-01-01T00:00:00Z</published>
    <summary type="text">Title: Unusual Location: Omental Ectopic Pregnancy Interesting Case Report
Authors: Tamara, Yosi; Singgih, Rendy
Abstract: Objective: Omentum pregnancy is an ectopic pregnancy in the abdominal cavity. The event has high morbidity and mortality.&#xD;
The purpose of this case is to present a rare case of abdominal ectopic pregnancy that occurred in a young woman.&#xD;
Methods: Case report.&#xD;
Results: A 22-year-old woman at 16 weeks gestation presented with abdominal pain and clinical shock. Examination results&#xD;
revealed pregnancy outside the womb, with an estimated fetal weight of 193 grams and positive heart activity. The patient&#xD;
underwent laparotomy surgery, revealing that the pregnancy had occurred in the omentum organ with placental attachment.&#xD;
Conclusion: In this case, emergency management began with the patient's reception in the emergency department, followed&#xD;
by laparotomy exploration. After a meticulous surgery, the pregnancy's location was identified in the omentum, and the&#xD;
evacuation of pregnancy products was performed. The patient received treatment for several days until being discharged&#xD;
home. Early diagnosis and interprofessional management are crucial if similar conditions are suspected in the future to prevent&#xD;
morbidity.</summary>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Mosaic Form of Turner Syndrome</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/10388" />
    <author>
      <name>Laqif, Abdurahman</name>
    </author>
    <author>
      <name>Wijayanti, Agung Sari</name>
    </author>
    <author>
      <name>Moelyo, Annang Giri</name>
    </author>
    <author>
      <name>Budihastuti, Uki Retno</name>
    </author>
    <author>
      <name>Melinawati, Eriana</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/10388</id>
    <updated>2025-06-05T03:42:53Z</updated>
    <published>2024-01-01T00:00:00Z</published>
    <summary type="text">Title: Mosaic Form of Turner Syndrome
Authors: Laqif, Abdurahman; Wijayanti, Agung Sari; Moelyo, Annang Giri; Budihastuti, Uki Retno; Melinawati, Eriana
Abstract: Objective: To report a case of breast growth disorder in a mosaic form of Turner Syndrome. Turner syndrome is a chromosomal&#xD;
condition characterized by small height and primary ovarian insufficiency that affects one in every 2500 female births.&#xD;
Mosaicism is likely to occur when monosomy X develops in only a few cells during development. The clinical presentation&#xD;
of Turner syndrome mosaicism is atypical, with symptom severity varying based on the number of affected cells. This case&#xD;
discusses issues with secondary sex development, including mild hyperandrogenism, and explores how combination hormonal&#xD;
treatment can aid in enhancing secondary sex development.&#xD;
Method: Case Report.&#xD;
Case: A 21-year-old woman presented with chief complaint of the lack of breast enlargement. She exhibited normal genitalia&#xD;
internally and externally and had a regular menstrual cycle. Karyotyping revealed a mosaic pattern of 45, X/46, XX (1&#xD;
percent/99%) with normal estradiol levels and elevated testosterone levels (indicating mild hyperandrogenism). The patient&#xD;
underwent two cycles of hormone therapy using Ethinyl Estradiol and Drospirenone, resulting in breast growth progression&#xD;
from Tanner stage 1 to Tanner stage 2.&#xD;
Conclusion: Mosaicism in Turner syndrome is plausible, and the severity of clinical symptoms correlates with the number of&#xD;
defective chromosomes. The presentation of Turner syndrome mosaicism varies, and therapy should be tailored to address&#xD;
specific symptoms. While breast development is observed in some girls with Turner Syndrome, instances of breast growth&#xD;
disorder may occur, involving estrogen activity and estrogen receptor sensitivity. Although the exact cause of impaired breast&#xD;
growth remains unknown, administering estrogen in such cases can improve secondary sexual characteristics.</summary>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Serum Vitamin D Levels, Visual Analog Scale Dysmenorrhea Score, and Endometriosis ASRM Classification: a Relationship Study</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/10387" />
    <author>
      <name>Abadi, Adnan</name>
    </author>
    <author>
      <name>Rizany, Selly</name>
    </author>
    <author>
      <name>Agustiansyah, Patiyus</name>
    </author>
    <author>
      <name>Nurtjahyo, Awan</name>
    </author>
    <author>
      <name>Irfanuddin</name>
    </author>
    <author>
      <name>Usman, Fatimah</name>
    </author>
    <author>
      <name>Hartati</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/10387</id>
    <updated>2025-06-05T03:39:19Z</updated>
    <published>2024-01-01T00:00:00Z</published>
    <summary type="text">Title: Serum Vitamin D Levels, Visual Analog Scale Dysmenorrhea Score, and Endometriosis ASRM Classification: a Relationship Study
Authors: Abadi, Adnan; Rizany, Selly; Agustiansyah, Patiyus; Nurtjahyo, Awan; Irfanuddin; Usman, Fatimah; Hartati
Abstract: Objective: To assess the correlation between vitamin D levels, dysmenorrhea intensity measured by the visual analogue scale&#xD;
(VAS), and the stage of endometriosis determined by the American Society of Reproductive Medicine (ASRM) grading score.&#xD;
Methods: A cross-sectional study was conducted involving 37 women diagnosed with suspected endometriosis who met the&#xD;
inclusion and exclusion criteria. The aim was to determine the correlation between vitamin D levels, dysmenorrhea VAS scores,&#xD;
and the ASRM endometriosis stage at RSUP Dr. Mohammad Hoesin Palembang from November 2021 to April 2022. Bivariate&#xD;
analysis was employed to assess correlation, utilizing Pearson's correlation test and the Spearman Rank correlation test as an&#xD;
alternative method.&#xD;
Results: There was a significant positive correlation between vitamin D levels and the VAS score for dysmenorrhea (r = 0.678;&#xD;
p = 0.000) and a very strong positive correlation between vitamin D levels and the degree of endometriosis (r = 0.774; p =&#xD;
0.000) based on Spearman Rho's correlation test.&#xD;
Conclusion: There is a significant relationship between vitamin D levels with the VAS score of dysmenorrhea and the degree&#xD;
of endometriosis ASRM.</summary>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

